Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

What implications does this carry for Ford and investors? The consequences are serious. Quality issues could damage consumer ...

Ford is outperforming the S&P 500 with strong Q1 results, solid cash flow, and bullish technicals, despite tariff risks. Find ...

Following employee pricing is another incentive push. If you follow Ford Motor Company (NYSE: F), or perhaps the auto ...

The inside story of how a CEO and a group of marketers made a last-minute change of plans that now has the Ford brand leading U.S. sales.

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...

Detailed price information for Ford Motor Company (F-N) from The Globe and Mail including charting and trades.

Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.

Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.

The Motley Fool. DATE Thursday, July 17, 2025 at 9 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Robert ...

The GMC Hummer EV outperformed Tesla's Cybertruck in the second quarter of 2025, with sales figures revealing a significant drop in Cybertruck purchases.